Replies to post #88946 on NanoViricides Inc. (NNVC)

[4theduration]

Duff McDonald is a takedown artist, and he doesn't bother to get so much as a live quote from NNVC, but he nonetheless makes a convincing case. Where are the respected industry experts and scientists to come to NNVC's defense?

[TheDane]

How did you find this article?

[daBoze]

Duff McDonald is a muck-raking journalist who has made a living through sensationalized stories about Wall Street and Big Business. Take this smear job for what it's worth.

[Ubertino]

In re -- a conjunctivitis drug --

Did you notice that NBC's Bob Costas missed some of the recent Olympic's broadcasts because he had pink eye? He would have appreciated some EKC-Cide!

http://www.dailymail.co.uk/news/article-2560921/Bob-Costas-returns-Olympic-coverage-Monday-pinkeye-infection-eyes.html

As to delays -true enough!

The bulk of that article is old news, regurgitated and stale, asked and answered a million times. But makes good reading for Martians!

Next!

[BonelessCat]

Some problems with half-truths:

My favorite early product name: SuperCide, a “novel microbicide that will be used in condoms and vaginal lubricants to minimize the spread of [STDs].” There was also Hivi-Cide-I, which promised to “neutralize and disable” HIV. In 2005, they were predicting the ability to cure HIV by 2009.

SuperCide was the working name for the original nanomicelle application where the cide targeted a bioform to deliver a drug. During a proof of concept in vitro study they found that the nanomicelle destroyed CMV upon contact. That was the shift from Supercides to nanoviricides that targeted specifically viruses. Anti-HIV is still in the works but Flucide is now the lead drug.

Clearly not the types to miss the chance to talk about something, the company announced its intention to go to Vietnam to do that talking, after which they intended to “redevelop” FluCide-I into AvianFlucide-I. In March 2006, they reported that the results from a mouse study of FluCide made the drug “worthy of filing an Investigational New Drug Application” with the F.D.A. Alas, it’s been eight years and not only has no I.N.D. been filed, there’s no longer any word of AvianFluicide on the company’s web site.

What this "reporter" ignores are the results where several versions of Flucide were tested against both Bird Flu (H5N1) and H1N1 human pathogens. In an aggressive protocol with TamiFlu as the challenge, all the animals given versions of FluCide outlived those given Tamiflu. The test drugs were AvianFlcide-1 which ghas since been replaced by the more effective broad spectrum FluCide currently approaching clinical trials.

What the reporter also seems to ignore is that the anti-Rabis nanoviricide was also tested and for the first time in medical history, 50% of animals were rescued, that is survived after treatment following the onset of Rabies symptoms. 50% of the animals were still alive at the end of the study while all the animals given the standard course as well as untreated died.

More to come later. Still, what a hack job this so-called reporter does in reporting in each case only half the facts, if even that.